ReWalk Robotics

ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Yokneam Ilit, Israel.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ReWalk Robotics Ltd. (NASDAQ:RWLK ) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Mike Lawless - Chief Financial Officer Larry Jasinski - Chief Executive Officer Conference Call Participants Swayampakula Ramakanth - H.C.

ReWalk Robotics Ltd. (RWLK) Q1 2023 Earnings Call Transcript

ReWalk Robotics (RWLK) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.07 per share a year ago.

ReWalk Robotics (RWLK) Reports Q1 Loss, Misses Revenue Estimates

On-Track Start to Fiscal Year  with Progress in Advancing Reimbursement Coverage for Medicare Beneficiaries

ReWalk Robotics Reports First Quarter 2023 Financial Results

ReWalk Robotics will unveil its innovative new exoskeleton to the public at the upcoming Abilities Expo in New York, with live demonstrations from paralyzed individuals who use the technology to regain ambulatory access to real-world environments, including stairs and curbs ReWalk Robotics will unveil its innovative new exoskeleton to the public at the upcoming Abilities Expo in New York, with live demonstrations from paralyzed individuals who use the technology to regain ambulatory access to real-world environments, including stairs and curbs

ReWalk Robotics to Provide First U.S. Demonstrations of Groundbreaking Stairs-Enabled Exoskeleton Technology

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, May 03, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that the Company will release its first quarter 2023 financial results before the markets open on Thursday, May 11, 2023.

ReWalk Robotics Ltd. to Report First Quarter Financial Results on May 11, 2023

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 03, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on May 10

Fintel reports that Lind Global Fund II has filed a 13D/A form with the SEC disclosing ownership of 9.60MM shares of Rewalk Robotics Ltd (RWLK).

Lind Global Fund II Now Owns 16.1% of Rewalk Robotics

Paralyzed individuals with spinal cord injury will have unprecedented access to walking in everyday environments as they are no longer limited when encountering stairs and curbs Paralyzed individuals with spinal cord injury will have unprecedented access to walking in everyday environments as they are no longer limited when encountering stairs and curbs

Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs

The court process in Germany came to a resolution in ReWalk's favor in the fall of 2022 without an actual court decision, as the insurer dropped the appeal. Sales were slowed down in 2022, but growth is anticipated for 2023 from German insurance payments and US Veterans' Affairs, with expanded geographical coverage for training at VA centers.

ReWalk Robotics: The Next Phase Hinges On Medicare

ReWalk Robotics Ltd. (NASDAQ:RWLK ) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Company Participants Mike Lawless - Chief Financial Officer Larry Jasinski - Chief Executive Officer Conference Call Participants Swayampakula Ramakanth - H.C.

ReWalk Robotics Ltd. (RWLK) Q4 2022 Earnings Call Transcript

ReWalk (RWLK) delivered earnings and revenue surprises of -28.57% and 3.76%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) Reports Q4 Loss, Tops Revenue Estimates

Strong Conclusion to 2022 – Q4'22 R evenue Highest Since Start of COVID -19 Pandemic

ReWalk Robotics Reports Fourth Quarter and Full Year 2022 Financial Results

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 16, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and fiscal year-end 2022 financial results on Thursday, February 23, 2023, at 8:30 AM Eastern time.

ReWalk Robotics to Report Fourth Quarter and Fiscal Year-End 2022 Financial Results on February 23, 2023

Reflects Confidence in Long-Term Potential of ReWalk Reflects Confidence in Long-Term Potential of ReWalk

ReWalk Announces Extension of Share Repurchase Program

Precedent set for all future cases as State Court verdict is legally binding and enforceable

Germany's second largest health insurer withdraws appeal with Federal Social Court, accepts prior ruling of exoskeletons as direct disability compensation

ReWalk Robotics Ltd. (NASDAQ:RWLK ) Q3 2022 Earnings Conference Call November 7, 2022 8:30 AM ET Company Participants Michael Lawless - CFO Larry Jasinski - CEO Conference Call Participants Operator Good day, and welcome to the Q3, 2022 ReWalk Robotics Limited Earnings Conference Call.

ReWalk Robotics Ltd. (RWLK) Q3 2022 Earnings Call Transcript

ReWalk (RWLK) delivered earnings and revenue surprises of -50% and 51.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) Reports Q3 Loss, Lags Revenue Estimates

ReWalk Has Submitted the First Case to Medicare Administrative Contractors (MACs) for Coverage and Reimbursement of the ReWalk Exoskeleton for Medicare Beneficiaries

ReWalk Robotics Reports Third Quarter 2022 Financial Results

MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Oct. 31, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2022 financial results on Monday, November 7, 2022, at 8:30 AM Eastern time.

ReWalk Robotics to Report Third Quarter 2022 Financial Results on November 7, 2022

MARLBOROUGH, Mass., Sept. 28, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”, or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, is announcing that the Company will begin submitting Medicare cases following CMS's September 26, 2022, announcement affirming that the MACs have discretion to cover and reimburse for the ReWalk exoskeleton. ReWalk Robotics is actively engaged with CMS in its commitment to evaluate complex advanced technologies like exoskeletons.

ReWalk Takes Another Step Toward Medicare Coverage

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the German Federal Social Court has scheduled a hearing to review the decision of whether an exoskeleton medical device should be classified as directly or indirectly compensating for the lost function of individuals with spinal cord injuries or paraplegia. The hearing is scheduled for November 10, 2022.

German Federal Social Court Schedules Hearing on Classification of Exoskeleton Medical Devices for Spinal Cord Injured Individuals

Brings Significant Experience in M&A, Investor Relations, and Financial Strategy Brings Significant Experience in M&A, Investor Relations, and Financial Strategy

ReWalk Robotics Appoints Michael Lawless as Chief Financial Officer

ReWalk Robotics Ltd. (NASDAQ:RWLK ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Almog Adar - Director of Finance Larry Jasinski - CEO Conference Call Participants Swayampakula Ramakanth - H.C.

ReWalk Robotics Ltd. (RWLK) CEO Larry Jasinki on Q2 2022 Results - Earnings Call Transcript

ReWalk (RWLK) delivered earnings and revenue surprises of -75% and 32.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) Reports Q2 Loss, Misses Revenue Estimates

Highlights June 8 th Milestone Participation at Biannual CMS HCPCS Public Meeting as Part of Efforts to Gain “Artificial Legs” Benefit Category Classification as Prosthetic for ReWalk Device

News for ReWalk Robotics Stock (RWLK)